Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 138
Selected: 0
NCT IDTitle
NCT00777894Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00004873Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00392691Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
NCT02467582Adjuvant Aspirin Treatment for Colon Cancer Patients
NCT00003757Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy
NCT00031876Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer
NCT00020566Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
NCT01707966Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy
NCT00002526Chemotherapy in Treating Patients With Advanced Sarcoma
NCT00003280Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma
NCT06090162LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma
NCT00005060Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
NCT05815927Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT06401980Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT00003230Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
NCT02833766Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer
NCT00568048Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
NCT04630730Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC
NCT00234026Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma
NCT03017326Paediatric Hepatic International Tumour Trial
NCT06452394NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
NCT00334594Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
NCT02964689Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.
NCT04480372SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II
NCT01009801Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer
NCT02933801ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.
NCT01101425Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT06284122Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
NCT00003231Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
NCT06358573Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
NCT03762122Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)
NCT03213301Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.
NCT04604067Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
NCT00030810Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC
NCT00238381Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer
NCT00031889Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
NCT02067741CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer
NCT01593241Therapy De-escalation in Seminoma Stage IIA/B
NCT00003746Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
NCT00516412Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
NCT02311569Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation
NCT04629781Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC
NCT036206691st Line Durvalumab in PS 2 NSCLC Patients
NCT01555281Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
NCT03406650Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.
NCT00568750Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
NCT00003214Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
NCT02356458Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
NCT00004935Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
NCT00227734Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery